Stock listing
NASDAQ:UNIS Unilife Corp Stock
Follow Unilife Corp into a list and get an email when it puts out news.
Last close · NASDAQ:UNIS
$0.159 USD
Close on Apr 20, 2017 · No longer trades
- Lowest – highest close
- $0.159 – $4.180 USDSince May 13, 2016 · lowest Apr 20, 2017 · highest Jul 15, 2016
Delisted NASDAQ:UNIS no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:UNIS
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Unilife Corp on 6ix
- Decks
- 33 decks · latest Nov 17, 2016
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (November 2016) | Investor deck | 13 slides | Nov 17, 2016 |
| Q4 and FY2016 Earnings Presentation | Earnings | 19 slides | Nov 2, 2016 |
| Earnings Presentation (July 2015) | Earnings | 23 slides | Jul 30, 2015 |
| Q2 FY2015 Earnings Presentation | Earnings | 15 slides | Feb 12, 2015 |
| Piper Jaffray Healthcare Conference 2014 | Conference | 15 slides | Dec 2, 2014 |
| Q1 FY2015 Earnings Presentation | Earnings | 12 slides | Nov 14, 2014 |
| Shareholder Meeting (November 2014) | Shareholder meeting | 32 slides | Nov 14, 2014 |
| Investor Presentation (October 2014) | Investor deck | 21 slides | Oct 6, 2014 |
| FY2014 Earnings Presentation | Earnings | 6 slides | Sep 10, 2014 |
| Q3 FY2014 Earnings Presentation | Earnings | 13 slides | May 14, 2014 |
All 33 decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Q2 FY2014 Earnings Presentation | Earnings | 9 slides | Feb 5, 2014 |
| Shareholder Meeting (November 2013) | Shareholder meeting | 38 slides | Nov 27, 2013 |
| Q1 FY2014 Earnings Presentation | Earnings | 9 slides | Nov 12, 2013 |
| Q4 FY2013 Earnings Presentation | Earnings | 7 slides | Sep 11, 2013 |
| Shareholder Meeting (August 2013) | Shareholder meeting | 11 slides | Aug 26, 2013 |
| Q3 FY2013 Earnings Presentation | Earnings | 10 slides | May 10, 2013 |
| Q2 FY2013 Earnings Presentation | Earnings | 19 slides | Feb 12, 2013 |
| Shareholder Meeting (December 2012) | Shareholder meeting | 32 slides | Dec 3, 2012 |
| Q1 FY2013 Earnings Presentation | Earnings | 20 slides | Nov 9, 2012 |
| Q4 FY2012 Earnings Presentation | Earnings | 22 slides | Jul 31, 2012 |
| Q3 2012 Earnings Presentation | Earnings | 18 slides | Apr 26, 2012 |
| Investor Presentation (April 2012) | Investor deck | 21 slides | Apr 18, 2012 |
| Shareholder Meeting (April 2012) | Shareholder meeting | 4 slides | Apr 18, 2012 |
| Q2 2012 Earnings Presentation | Earnings | 21 slides | Feb 10, 2012 |
| Shareholder Meeting (December 2011) | Shareholder meeting | 43 slides | Dec 5, 2011 |
| Q1 2012 Earnings Presentation | Earnings | 17 slides | Nov 9, 2011 |
| FY2011 Earnings Presentation | Earnings | 24 slides | Aug 30, 2011 |
| Q3 FY2011 Earnings Presentation | Earnings | 13 slides | May 16, 2011 |
| Q2 2011 Earnings Presentation | Earnings | 16 slides | Feb 14, 2011 |
| Shareholder Meeting (December 2010) | Shareholder meeting | 48 slides | Dec 6, 2010 |
| Q1 FY2011 Earnings Presentation | Earnings | 20 slides | Nov 15, 2010 |
| FY2010 Earnings Presentation | Earnings | 19 slides | Aug 31, 2010 |
| Investor Presentation (February 2010) | Investor deck | 22 slides | Feb 17, 2010 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| David Hastings Other companies: Trevi Therapeutics, Inc. (Chief Financial Officer · Since at least Dec 4, 2025); Scynexis, Inc. (Director · Since at least Sep 24, 2015); Vascular Biogenics Ltd (Director · Jan 1, 2023 – Jan 1, 2023 · Past); Entasis Therapeutics Holdings Inc (Director · Sep 25, 2018 – Jul 7, 2022 · Past); Arbutus Biopharma Corporation (Chief Financial Officer · Jun 11, 2018 – Feb 14, 2025 · Past); Incyte Corporation (Chief Financial Officer · Jan 13, 2006 – Jun 4, 2014 · Past) | See Remarks · Feb 23, 2015 – Jan 26, 2017 · Past |
| Michael E Kamarck Other companies: Passage Bio, Inc. (Director · Jul 2, 2022 – May 25, 2023 · Past); Vaxcyte, Inc. (Director · Oct 27, 2021 – Jun 13, 2023 · Past); Trillium Therapeutics Inc (Director · Jan 1, 2021 – Nov 17, 2021 · Past); Vir Biotechnology, Inc. (Chief Technology Officer · Oct 10, 2019 – Oct 10, 2019 · Past); Omni Bio Pharmaceutical Inc (Director · Jan 31, 2013 – Jan 31, 2013 · Past) | Director · Jul 28, 2016 – Jul 28, 2016 · Past |
| Rosemary A. Crane Other companies: Certara, Inc. (Director · Since at least Jul 21, 2022); Teva Pharmaceutical Industries Limited (Independent Director · Since at least Jan 1, 2018); Tarsus Pharmaceuticals, Inc. (Director · Aug 11, 2021 – Jun 24, 2024 · Past); Catalent Inc (Director · Feb 16, 2018 – Oct 27, 2023 · Past); PDS Biotechnology Corporation (Director · Sep 18, 2017 – Mar 15, 2019 · Past) | Director · Oct 28, 2016 – Oct 28, 2016 · Past |
| Duane M DeSisto Other companies: Modular Medical, Inc. (Director · Since at least Jul 5, 2023); Stereotaxis, Inc. (Director · Apr 30, 2015 – May 24, 2016 · Past); Insulet Corporation (President and CEO, Director · Feb 26, 2009 – Sep 2, 2014 · Past); LeMaitre Vascular, Inc. (Director · Oct 18, 2006 – Jul 18, 2007 · Past) | Director · Oct 28, 2016 – Oct 28, 2016 · Past |
| J Christopher Naftzger Other companies: Arbutus Biopharma Corporation (General Counsel and CCO · Jul 10, 2023 – Feb 14, 2025 · Past); Nabriva Therapeutics AG (General Counsel and Corp Sec · Jan 28, 2021 – Aug 11, 2022 · Past) | See Remarks · Jul 6, 2010 – May 28, 2013 · Past |
| Marc S Firestone Other companies: Philip Morris International Inc (Pres Ext Aff & Gen Counsel · Apr 16, 2012 – Aug 10, 2020 · Past); Mondelez International, Inc. (EVP and General Counsel · Jan 24, 2006 – Feb 23, 2012 · Past) | Director · Jul 27, 2010 – Jun 29, 2012 · Past |
| R Richard Wieland Other companies: BioVie Inc. (Director · Sep 24, 2017 – Jun 30, 2020 · Past); Advanced Life Sciences Holdings Inc (EVP & Chief Financial Officer · Mar 10, 2006 – Nov 19, 2008 · Past) | See Remarks · Jun 8, 2010 – May 28, 2013 · Past |
| Alan Shortall | Chief Executive Officer, Director · Feb 11, 2010 – Mar 14, 2016 · Past |
| Daniel Calvert | Chief Financial Officer · Feb 11, 2010 – Feb 11, 2010 · Past |
| Dennis Pyers | See Remarks · Jul 27, 2010 – Sep 15, 2015 · Past |
All 25 people
| Person | Seat |
|---|---|
| Eugene Shortall | See Remarks · Feb 11, 2010 – May 19, 2011 · Past |
| Harry A Hamill | Director · Aug 25, 2015 – Nov 18, 2015 · Past |
| Ian Hanson | See Remarks · Mar 14, 2016 – Jan 26, 2017 · Past |
| Jeff Carter | Director · Feb 11, 2010 – Nov 18, 2015 · Past |
| Jim Bosnjak | Director · Feb 11, 2010 – Nov 17, 2014 · Past |
| John C Ryan | See Remarks · May 8, 2014 – Mar 3, 2015 · Past |
| John Lund | Director · Nov 18, 2015 – Nov 18, 2015 · Past |
| Mark Iampietro | See Remarks · Feb 11, 2010 – Mar 3, 2015 · Past |
| Mary Katherine Wold | Director · May 11, 2010 – Nov 18, 2015 · Past |
| Michael Ratigan | See Remarks · Mar 14, 2016 – Jan 26, 2017 · Past |
| Molly Weaver | See Remarks · Jul 28, 2016 – Jan 26, 2017 · Past |
| Ramin Mojdehbakhsh | See Remarks · Feb 7, 2011 – Mar 14, 2016 · Past |
| Stephanie Walters | See Remarks · Jul 28, 2016 – Jan 26, 2017 · Past |
| Stephen Allan | See Remarks · Feb 11, 2010 – Jan 3, 2011 · Past |
| William Galle | Director · Feb 11, 2010 – Nov 18, 2015 · Past |
Log in to ask 6ix AI your own questions about Unilife Corp.